4-pyridin-4-yl-N-[[3-[[(1S,5R)-1,5,8-trimethyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]phenyl]methyl]benzamide
C29H33N3O2 — CID 12000921
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-pyridin-4-yl-N-[[3-[[(1S,5R)-1,5,8-trimethyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]phenyl]methyl]benzamide
4-pyridin-4-yl-N-[[3-[[(1S,5R)-1,5,8-trimethyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]phenyl]methyl]benzamide (PubChem CID 12000921) has the molecular formula C29H33N3O2 and a molecular weight of 455.60 g/mol. Its IUPAC name is 4-pyridin-4-yl-N-[[3-[[(1S,5R)-1,5,8-trimethyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]phenyl]methyl]benzamide.
Molecular Properties
| Compound Name | 4-pyridin-4-yl-N-[[3-[[(1S,5R)-1,5,8-trimethyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]phenyl]methyl]benzamide |
|---|---|
| PubChem CID | 12000921 |
| Molecular Formula | C29H33N3O2 |
| Molecular Weight | 455.60 g/mol |
| Exact Mass | 455.26 |
| IUPAC Name | 4-pyridin-4-yl-N-[[3-[[(1S,5R)-1,5,8-trimethyl-8-azabicyclo[3.2.1]octan-3-yl]oxy]phenyl]methyl]benzamide |
| SMILES | CN1[C@@]2(C)CC[C@]1(C)CC(Oc1cccc(CNC(=O)c3ccc(-c4ccncc4)cc3)c1)C2 |
| InChI | InChI=1S/C29H33N3O2/c1-28-13-14-29(2,32(28)3)19-26(18-28)34-25-6-4-5-21(17-25)20-31-27(33)24-9-7-22(8-10-24)23-11-15-30-16-12-23/h4-12,15-17,26H,13-14,18-20H2,1-3H3,(H,31,33)/t26?,28-,29+ |
| InChIKey | IGXHUEWDVVCGCQ-CSDGHANUSA-N |
| XLogP | 5.46 |
| TPSA | 54.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.60 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 12000921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.